News & Events

December 22, 2021

Transcranial Magnetic Stimulation Shows Promise for Alcohol Addiction

Proof-of-concept research on Deep TMS as a treatment for alcohol dependence, with commentary from Dr....

December 9, 2021

BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects

Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol...

December 1, 2021

Houston doctors using brain stimulation helmet to treat depression

A behind the curtains look at Deep TMS treatment and how it is currently providing relief for a local...

October 26, 2021

COVID-19 has accelerated the mental health crisis

The importance of mental health is highlighted, with statements from BrainsWay and Chief Medical Officer...

November 30, 2021

BrainsWay to Present at the Sidoti December Micro-Cap Investor Conference

BURLINGTON, Mass. and JERUSALEM, November 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

November 17, 2021

BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights

Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System...

November 3, 2021

BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021

BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

October 12, 2021

BrainsWay Announces Prominent Addition to Scientific Advisory Board

Zafiris Daskalakis, MD, PhD to Bring Extensive Research and Clinical Expertise to Assist in Guiding Growth...

September 30, 2021

BrainsWay Announces Data Published in World Psychiatry on Deep Transcranial Magnetic Stimulation (Deep TMS™) for Smoking Addiction

Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction BURLINGTON,...

September 20, 2021

MUSC Health among first to offer brain stimulation to try to help smokers quit

Patient testimonials, smoker statistics, and discussion around BrainsWay’s Deep TMS smoking addiction...

September 20, 2021

Mental Health Recap: 4 Must-Read Studies From August 2021

Highlighting the recent FDA clearance for anxious depression with references to the study and a quote...

September 9, 2021

BrainsWay featured on CBS News

Dr. Tendler discusses how emerging technologies, such as BrainsWay’s Deep TMS™, offer hope to...

September 7, 2021

Setting Your Company Up for Success When Navigating Coverage Conversations

BrainsWay CEO and President, Christopher von Jako, PhD discusses the navigation, education, and partner...

September 9, 2021

BrainsWay to Participate in Two Upcoming Investor Conferences in 2021

BURLINGTON, Mass. and JERUSALEM, Sept. 09, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

August 30, 2021

BrainsWay to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BURLINGTON, Mass. and JERUSALEM, August 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

August 25, 2021

Transcranial Magnetic Stimulation Device Cleared for Anxious Depression

Summary of the release and research lending to the FDA-clearance of anxious depression, with quotes from...

August 20, 2021

BrainsWay receives FDA clearance for noninvasive comorbid anxiety, depression treatment

Summary of the release, highlighting how this FDA clearance will allow BrainsWay to increase patient...

August 19, 2021

FDA clearance for Deep TMS system in decreasing anxiety symptoms

FDA Clearance for Deep TMS system in decreasing anxiety symptoms in depressed patients, as well as highlights...